DAFNA Capital Management’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-12,845
| Closed | -$160K | – | 84 |
|
|
2024
Q3 | $160K | Hold |
12,845
| – | – | 0.04% | 84 |
|
|
2024
Q2 | $167K | Hold |
12,845
| – | – | 0.04% | 81 |
|
|
2024
Q1 | $291K | Hold |
12,845
| – | – | 0.07% | 68 |
|
|
2023
Q4 | $167K | Hold |
12,845
| – | – | 0.04% | 73 |
|
|
2023
Q3 | $258K | Hold |
12,845
| – | – | 0.08% | 68 |
|
|
2023
Q2 | $345K | Hold |
12,845
| – | – | 0.09% | 64 |
|
|
2023
Q1 | $750K | Hold |
12,845
| – | – | 0.22% | 54 |
|
|
2022
Q4 | $655K | Buy |
+12,845
| New | +$655K | 0.18% | 58 |
|